Expertise in
25
conditions

Dr. Brad Herskowitz

Sleep Medicine
Office
9055 SW 87th Ave Ste 100, 
Miami, FL 
Offers Telehealth
Expertise in
25
conditions
Office
9055 SW 87th Ave Ste 100, 
Miami, FL 

Overview

Brad Herskowitz is a Sleep Medicine provider in Miami, Florida. Dr. Herskowitz is highly rated in 25 conditions, according to our data. His top areas of expertise are New Daily Persistent Headache (NDPH), Transient Ischemic Attack (TIA), Transient Global Amnesia, and Generalized Tonic-Clonic Seizure.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Sleep Medicine

Licenses

Psychiatry & Neurology in FL

Hospital Affiliations

Baptist Hospital Of Miami
Doctors Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Office
9055 SW 87th Ave Ste 100, Miami, FL 33176

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Longitudinal Cohort Study of Resource Use and Cost of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in the United States (GERAS-US)
Longitudinal Cohort Study of Resource Use and Cost of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in the United States (GERAS-US)
Enrollment Status: Active_not_recruiting
Publish Date: October 24, 2025
Intervention Type: Drug
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 22, 2025
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Drug
Study Drug: LY3372689
Study Phase: Phase 2
XanADu: A Phase II, Double-Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to Alzheimer's Disease (AD)
XanADu: A Phase II, Double-Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to Alzheimer's Disease (AD)
Enrollment Status: Completed
Publish Date: February 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease
A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Drug
Study Drugs: Donanemab, Aducanumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 19, 2024
Intervention Type: Drug
Study Drug: T3D-959
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia
Enrollment Status: Completed
Publish Date: February 14, 2024
Intervention Type: Drug
Study Drug: ABP-450
Study Phase: Phase 2
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

3 Total Publications

A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease.
A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease.
Journal: The journal of prevention of Alzheimer's disease
Published: January 03, 2025
Similar Doctors
Expertise in
3
conditions
Dr. Harneet Walia
Sleep Medicine
Expertise in
3
conditions
Dr. Harneet Walia
Sleep Medicine

Baptist Health Cardiology & Sleep Medicine | Kendall (Galloway)

7400 SW 87th Ave Ste 100, 
Miami, FL 
 (1.9 miles away)
786-345-7208
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Harneet Walia is a Sleep Medicine provider in Miami, Florida. Dr. Walia is highly rated in 3 conditions, according to our data. Her top areas of expertise are Obstructive Sleep Apnea, Restless Legs Syndrome, Insomnia, and REM Behavior Disorder.

Expertise in
11
conditions
Dr. Timothy Grant
Sleep Medicine
Expertise in
11
conditions
Dr. Timothy Grant
Sleep Medicine

Office

3911 SW 67th Ave, 
Miami, FL 
 (3.9 miles away)
305-665-5552
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Timothy Grant is a Sleep Medicine provider in Miami, Florida. Dr. Grant is highly rated in 11 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, REM Behavior Disorder, Insomnia, and Sleep Paralysis.

Expertise in
32
conditions
Dr. Ravali Tarigopula
Sleep Medicine
Expertise in
32
conditions
Dr. Ravali Tarigopula
Sleep Medicine

Nuview Health

1825 NW Corporate Blvd, 
Boca Raton, FL 
 (49.2 miles away)
561-299-3667
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ravali Tarigopula is a Sleep Medicine provider in Boca Raton, Florida. Dr. Tarigopula is highly rated in 32 conditions, according to our data. Her top areas of expertise are Idiopathic Hypersomnia, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Asthma, and Advanced Bronchoscopy.

Frequently Asked Questions about Dr. Brad Herskowitz

How do I make an appointment with Dr. Brad Herskowitz?

You can book an appointment with Dr. Brad Herskowitz by calling their office at 305-596-2080. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Brad Herskowitz a top-rated expert for New Daily Persistent Headache (NDPH)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Brad Herskowitz is classified as an Distinguished expert for New Daily Persistent Headache (NDPH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Brad Herskowitz specialize in?

While Dr. Brad Herskowitz is a Sleep Medicine, they have specific expertise in New Daily Persistent Headache (NDPH), Transient Ischemic Attack (TIA), and Transient Global Amnesia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Sleep Medicine.

Does Dr. Brad Herskowitz participate in research or clinical trials?

Yes. Dr. Brad Herskowitz has published 3 articles and abstracts on conditions like New Daily Persistent Headache (NDPH). You can view a list of Dr. Brad Herskowitz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Brad Herskowitz accept my insurance?

Dr. Brad Herskowitz accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 305-596-2080 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Herskowitz's expertise for a condition
ConditionClose
    View All 24 Advanced Conditions
    View All 125 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile